Market revenue in 2024 | USD 30.5 million |
Market revenue in 2030 | USD 65.2 million |
Growth rate | 13.5% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.2% in 2024. Horizon Databook has segmented the Sweden pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The pancreatic cancer treatment market in Sweden is projected to experience substantial growth due to an increase in incidence rates and the rising economic burden associated with the disease. According to WHO.
The number of pancreatic cancer cases in Sweden is expected to grow by 15% to 28% by 2030, with the total number of cases increasing from 1,352 in 2018 to between 1,554 and 1,736 by 2030. This surge in cases is expected to contribute to a significant rise in treatment costs.
Which are projected to increase Sweden’s healthcare system faces the challenge of accommodating the growing demand for pancreatic cancer treatments while managing limited resources.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden pancreatic cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Sweden pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account